GenSight BiologicsSIGHT 
$0.28-1.63%24h
-1.63%24h
Global rank28039
Market cap$18.33M
Change 7d-14.22%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of GenSight Biologics (SIGHT)
As of January 2025, GenSight Biologics has a market cap of $18.33M. This makes GenSight Biologics the world's 28039th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of GenSight Biologics from 2016 to 2024
-
Value:-
Market cap history of GenSight Biologics from 2016 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $26.73M | -13.91% |
| 2023 | $31.05M | -86.32% |
| 2022 | $226.96M | -39.53% |
| 2021 | $375.34M | -22.02% |
| 2020 | $481.33M | 186.92% |
| 2019 | $167.76M | -25.38% |
| 2018 | $224.80M | -46.12% |
| 2017 | $417.20M | -20.26% |
| 2016 | $523.19M | - |
SIGHT Market Cap Today is $18.33M -1.63% - 20 Jan 2025
View largest stocks by market cap 
